Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HVQ3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.711 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.701 |
CLV_PCSK_FUR_1 | 26 | 30 | PF00082 | 0.462 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.726 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.719 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.676 |
CLV_PCSK_PC1ET2_1 | 109 | 111 | PF00082 | 0.726 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.719 |
CLV_PCSK_PC1ET2_1 | 28 | 30 | PF00082 | 0.450 |
CLV_PCSK_PC7_1 | 63 | 69 | PF00082 | 0.676 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.658 |
DOC_CKS1_1 | 10 | 15 | PF01111 | 0.680 |
DOC_CKS1_1 | 62 | 67 | PF01111 | 0.466 |
DOC_CYCLIN_RxL_1 | 63 | 72 | PF00134 | 0.555 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.457 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.685 |
LIG_14-3-3_CanoR_1 | 124 | 131 | PF00244 | 0.562 |
LIG_14-3-3_CanoR_1 | 26 | 32 | PF00244 | 0.656 |
LIG_14-3-3_CanoR_1 | 89 | 94 | PF00244 | 0.511 |
LIG_Clathr_ClatBox_1 | 39 | 43 | PF01394 | 0.507 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.520 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.702 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.522 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.642 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.557 |
LIG_SUMO_SIM_par_1 | 38 | 43 | PF11976 | 0.503 |
LIG_TYR_ITIM | 55 | 60 | PF00017 | 0.311 |
MOD_CDK_SPxK_1 | 61 | 67 | PF00069 | 0.463 |
MOD_CDK_SPxxK_3 | 61 | 68 | PF00069 | 0.467 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.459 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.498 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.485 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.577 |
MOD_CK1_1 | 98 | 104 | PF00069 | 0.418 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.560 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.547 |
MOD_Cter_Amidation | 65 | 68 | PF01082 | 0.680 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.716 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.577 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.396 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.481 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.471 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.445 |
MOD_LATS_1 | 140 | 146 | PF00433 | 0.450 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.504 |
MOD_PK_1 | 89 | 95 | PF00069 | 0.470 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.523 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.536 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.478 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.472 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.463 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.683 |
TRG_DiLeu_BaLyEn_6 | 65 | 70 | PF01217 | 0.557 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.365 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.425 |
TRG_Pf-PMV_PEXEL_1 | 67 | 71 | PF00026 | 0.767 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P887 | Leptomonas seymouri | 48% | 100% |
A0A3S5H6P6 | Leishmania donovani | 99% | 100% |
A4H7A8 | Leishmania braziliensis | 67% | 97% |
Q4QG29 | Leishmania major | 87% | 100% |